PRESS RELEASE published on 09/12/2023 at 16:15, 1 year ago Margulies Perruzzi Completes Phase One of New HQ for Boston Scores
PRESS RELEASE published on 06/13/2023 at 16:15, 1 year 3 months ago Margulies Perruzzi Adds Jane Kepros as Director of Lab Programming
PRESS RELEASE published on 04/05/2023 at 16:15, 1 year 5 months ago Margulies Perruzzi Completes 31,000 SF Office Renovation for Boston Trust Walden
PRESS RELEASE published on 03/21/2023 at 15:15, 1 year 5 months ago Margulies Perruzzi Completes Renovation for Radiation Oncology at Beth Israel Lahey Health’s Winchester Hospital
PRESS RELEASE published on 01/25/2023 at 16:15, 1 year 7 months ago Margulies Perruzzi Completes Lab/Office Space for Strand Therapeutics
Published on 09/20/2024 at 23:40, 5 hours 37 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 47 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 6 hours 17 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 6 hours 47 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 7 hours 2 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 6 hours 18 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 8 hours 17 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 9 hours 2 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours 27 minutes ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 30 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 37 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 37 minutes ago Mise à disposition du Rapport Financier Semestriel 2024